ExploreWatchlistsPricing
  1. US-listed companies
  2. Novo Integrated Sciences, Inc.
  3. Financials
  4. Capital expenditures

Novo Integrated Sciences, Inc. (NVOS)

Market cap
$76.95K
P/E ratio
SummaryFinancials
Period EndCapital expenditures (Million USD)YoY (%)
Aug 31, 2024-0-89.77%
Aug 31, 2023-0-74.12%
Aug 31, 2022-0-25.70%
Aug 31, 2021-0+2013.53%
Aug 31, 2020-0-90.83%
Aug 31, 2019-0-26.07%
Aug 31, 2018-0+367.14%
Aug 31, 2017-0-44.21%
Dec 31, 2013-0+0.00%
Dec 31, 2012-0+28.02%
Dec 31, 2011-0

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat